181 related articles for article (PubMed ID: 24961874)
1. Discovery of novel inhibitors of vascular endothelial growth factor-A-Neuropilin-1 interaction by structure-based virtual screening.
Starzec A; Miteva MA; Ladam P; Villoutreix BO; Perret GY
Bioorg Med Chem; 2014 Aug; 22(15):4042-8. PubMed ID: 24961874
[TBL] [Abstract][Full Text] [Related]
2. Identification of Four New Chemical Series of Small Drug-Like Natural Products as Potential Neuropilin-1 Inhibitors by Structure-Based Virtual Screening: Pharmacophore-Based Molecular Docking and Dynamics Simulation.
Sabki A; Khelifi L; Kameli A; Baali S
Chem Biodivers; 2023 Mar; 20(3):e202200933. PubMed ID: 36799050
[TBL] [Abstract][Full Text] [Related]
3. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1.
Starzec A; Vassy R; Martin A; Lecouvey M; Di Benedetto M; Crépin M; Perret GY
Life Sci; 2006 Nov; 79(25):2370-81. PubMed ID: 16959272
[TBL] [Abstract][Full Text] [Related]
4. VEGF-A165 induces human aortic smooth muscle cell migration by activating neuropilin-1-VEGFR1-PI3K axis.
Banerjee S; Mehta S; Haque I; Sengupta K; Dhar K; Kambhampati S; Van Veldhuizen PJ; Banerjee SK
Biochemistry; 2008 Mar; 47(11):3345-51. PubMed ID: 18284215
[TBL] [Abstract][Full Text] [Related]
5. Expression of the vascular endothelial growth factor receptor neuropilin-1 in the human endometrium.
Hess AP; Schanz A; Baston-Buest DM; Hirchenhain J; Stoff-Khalili MA; Bielfeld P; Kruessel JS
J Reprod Immunol; 2009 Jan; 79(2):129-36. PubMed ID: 18996601
[TBL] [Abstract][Full Text] [Related]
6. Molecular modelling, synthesis and biological evaluation of peptide inhibitors as anti-angiogenic agent targeting neuropilin-1 for anticancer application.
Kamarulzaman EE; Vanderesse R; Gazzali AM; Barberi-Heyob M; Boura C; Frochot C; Shawkataly O; Aubry A; Wahab HA
J Biomol Struct Dyn; 2017 Jan; 35(1):26-45. PubMed ID: 26766582
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and in vitro biological evaluation of a small cyclic peptide as inhibitor of vascular endothelial growth factor binding to neuropilin-1.
Grabowska K; Puszko AK; Lipiński PFJ; Laskowska AK; Wileńska B; Witkowska E; Misicka A
Bioorg Med Chem Lett; 2016 Jun; 26(12):2843-2846. PubMed ID: 27142754
[TBL] [Abstract][Full Text] [Related]
8. Structure-function analysis of the antiangiogenic ATWLPPR peptide inhibiting VEGF(165) binding to neuropilin-1 and molecular dynamics simulations of the ATWLPPR/neuropilin-1 complex.
Starzec A; Ladam P; Vassy R; Badache S; Bouchemal N; Navaza A; du Penhoat CH; Perret GY
Peptides; 2007 Dec; 28(12):2397-402. PubMed ID: 17983687
[TBL] [Abstract][Full Text] [Related]
9. Sugar-based peptidomimetics as potential inhibitors of the vascular endothelium growth factor binding to neuropilin-1.
Novoa A; Pellegrini-Moïse N; Bechet D; Barberi-Heyob M; Chapleur Y
Bioorg Med Chem; 2010 May; 18(9):3285-98. PubMed ID: 20363638
[TBL] [Abstract][Full Text] [Related]
10. Orf virus VEGF-E NZ2 promotes paracellular NRP-1/VEGFR-2 coreceptor assembly via the peptide RPPR.
Cébe-Suarez S; Grünewald FS; Jaussi R; Li X; Claesson-Welsh L; Spillmann D; Mercer AA; Prota AE; Ballmer-Hofer K
FASEB J; 2008 Aug; 22(8):3078-86. PubMed ID: 18467594
[TBL] [Abstract][Full Text] [Related]
11. Branched pentapeptides as potent inhibitors of the vascular endothelial growth factor 165 binding to Neuropilin-1: Design, synthesis and biological activity.
Tymecka D; Puszko AK; Lipiński PFJ; Fedorczyk B; Wilenska B; Sura K; Perret GY; Misicka A
Eur J Med Chem; 2018 Oct; 158():453-462. PubMed ID: 30241012
[TBL] [Abstract][Full Text] [Related]
12. Targeting neuropilin-1 to inhibit VEGF signaling in cancer: Comparison of therapeutic approaches.
Mac Gabhann F; Popel AS
PLoS Comput Biol; 2006 Dec; 2(12):e180. PubMed ID: 17196035
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of neuropilin-1 by basic fibroblast growth factor enhances vascular smooth muscle cell migration in response to VEGF.
Liu W; Parikh AA; Stoeltzing O; Fan F; McCarty MF; Wey J; Hicklin DJ; Ellis LM
Cytokine; 2005 Dec; 32(5):206-12. PubMed ID: 16289960
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and structure-activity relationship of non-peptidic antagonists of neuropilin-1 receptor.
Liu WQ; Megale V; Borriello L; Leforban B; Montès M; Goldwaser E; Gresh N; Piquemal JP; Hadj-Slimane R; Hermine O; Garbay C; Raynaud F; Lepelletier Y; Demange L
Bioorg Med Chem Lett; 2014 Sep; 24(17):4254-9. PubMed ID: 25091928
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationship study of a small cyclic peptide H-c[Lys-Pro-Glu]-Arg-OH: a potent inhibitor of Vascular Endothelial Growth Factor interaction with Neuropilin-1.
Grabowska K; Puszko AK; Lipiński PF; Laskowska AK; Wileńska B; Witkowska E; Perret GY; Misicka A
Bioorg Med Chem; 2017 Jan; 25(2):597-602. PubMed ID: 27889287
[TBL] [Abstract][Full Text] [Related]
16. Synergistic Binding of Vascular Endothelial Growth Factor-A and Its Receptors to Heparin Selectively Modulates Complex Affinity.
Teran M; Nugent MA
J Biol Chem; 2015 Jun; 290(26):16451-62. PubMed ID: 25979342
[TBL] [Abstract][Full Text] [Related]
17. Neuropilin-1 is required for endothelial cell adhesion to soluble vascular endothelial growth factor receptor 1.
Colotti G; Failla CM; Lacal PM; Ungarelli M; Ruffini F; Di Micco P; Orecchia A; Morea V
FEBS J; 2022 Jan; 289(1):183-198. PubMed ID: 34252269
[TBL] [Abstract][Full Text] [Related]
18. Urea moiety as amide bond mimetic in peptide-like inhibitors of VEGF-A
Puszko AK; Sosnowski P; Pułka-Ziach K; Hermine O; Hopfgartner G; Lepelletier Y; Misicka A
Bioorg Med Chem Lett; 2019 Sep; 29(17):2493-2497. PubMed ID: 31326342
[TBL] [Abstract][Full Text] [Related]
19. Relative effects of VEGF-A and VEGF-C on endothelial cell proliferation, migration and PAF synthesis: Role of neuropilin-1.
Bernatchez PN; Rollin S; Soker S; Sirois MG
J Cell Biochem; 2002; 85(3):629-39. PubMed ID: 11968003
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of selective VEGF-A binding by neuropilin-1 reveals a basis for specific ligand inhibition.
Parker MW; Xu P; Guo HF; Vander Kooi CW
PLoS One; 2012; 7(11):e49177. PubMed ID: 23145112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]